← Open Payments lookup

MEGAN JONES: Open Payments

NPI 1215635966 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,636 in 80 payments from 22 companies in 2025. Trend: 2023 $295 · 2024 $2,080 · 2025 $1,636

Food & beverage: $1,636
CompanyPaymentsAmount
Novo Nordisk Inc15$352
Lilly USA, LLC11$233
ABBVIE INC.8$140
Boehringer Ingelheim Pharmaceuticals, Inc.6$137
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
PFIZER INC.4$72
AstraZeneca Pharmaceuticals LP3$66
Exact Sciences Corporation3$54
Dexcom, Inc.3$48

Products named: MOUNJARO, Rybelsus, JARDIANCE, Ozempic, XIFAXAN, VRAYLAR, CAPLYTA, Dexcom G6 Transmitter.

Industry payments across MD — which companies pay providers there.